摘要
目的 建立同时测定人血清、脑脊液、胰液中利奈唑胺药物浓度的HPLC测定方法。方法 以利培酮为内标物,在0.1 mol·L-1NaOH碱性条件下甲基叔丁基醚-正丙醇=90∶10(V/V)液液提取,Shima-pack CLC-ODS-C18(6.0 mm×150 mm,5 μm)色谱柱分离,流动相为甲醇-乙腈-磷酸缓冲溶液(0.02 mol·L-1KH2PO4,H3PO4调pH 3.5)=20∶16∶64(V/V/V),流速1.0 mL·min-1,柱温35 ℃,检测波长254 nm条件下测定。结果 血清中利奈唑胺在0.25~40.0 mg·L-1内线性良好(r=0.999 9),3个浓度质控样本(0.8、8.0、25.0 mg·L-1)的批内、批间变异(RSD)分别为1.64%~2.38%(n=5)、4.53%~6.34%(n=5),方法学和提取回收率分别为93.781%~97.393%(n=5)、72.318%~73.442%(n=5);脑脊液中在0.1~20.0 mg·L-1内线性良好(r=0.999 3),3个浓度质控样本(0.2、2.0、15.0 mg·L-1)的批内、批间变异(RSD)分别为3.84%~4.83%(n=5)、6.04%~8.16%(n=5),方法学和提取回收率分别为106.910%~110.971%(n=5)、73.226%~80.603%(n=5);胰液中在0.1~20.0 mg·L-1内线性良好(r=0.999 4),3个浓度质控样本(0.2、2.0、15.0 mg·L-1)的批内、批间变异(RSD)分别为2.96%~5.30%(n=5)、4.68%~6.40%(n=5),方法学和提取回收率分别为97.178%~105.072%(n=5)、73.333%~76.010%(n=5)。内标提取回收率>87%。结论 本方法灵敏度高,准确性好,简便快捷,应用液液提取处理样本去除更多杂峰干扰,更广泛适用于临床,尤其适用于合并用药患者生物标本中利奈唑胺药物浓度的测定。
Abstract
OBJECTIVE To develop a high-performance liquid chromatographic (HPLC) method for determination of linezolid in human serum, cerebrospinal fluid (CSF) and pancreatic juice. METHODS With risperidone as internal standard, samples were extracted by methyl tert-butyl ether-n-propanol=90∶10 (V/V) after added 0.1 mol·L-1NaOH, then seperated on a Shima-pack CLC-ODS-C18(6.0 mm×150 mm, 5 μm) column with mobile phase consisted of methanol-acetonitrile-phosphate buffer solution (0.02 mol·L-1 KH2PO4, pH value was adjusted to about 3.5 by H3PO4)=20∶16∶64(V/V/V) with a flow rate of 1.0 mL·min-1 at 35 ℃. The detection wavelength was set at 254 nm. RESULTS For serum, the linear range of linezolid was from 0.25 to 40.0 mg·L-1(r=0.999 9). For the three check samples(0.8, 8.0, 25.0 mg·L-1): the intra-run and inter-run RSDs were 1.64%-2.38% (n=5) and 4.53%~6.34% (n=5) respectively, the mean method recoveries and extraction recoveries were 93.781%-97.393%(n=5) and 72.318%-73.442% (n=5) respectively. For cerebrospinal fluid, the linear range of linezolid was from 0.1 to 20.0 mg·L-1(r=0.999 3). For the three check samples(0.2, 2.0, 15.0 mg·L-1): the intra-run and inter-run RSDs were 3.84%-4.83% (n=5) and 6.04%-8.16% (n=5) respectively, the mean method recoveries and extraction recoveries were 106.910%-110.971% (n=5) and 73.226%-80.603% (n=5) respectively. For pancreatic juice, the linear range of linezolid was from 0.1 to 20.0 mg·L-1(r=0.999 4).For the three check samples(0.2, 2.0, 15.0 mg·L-1): the intra-run and inter-run RSDs were 2.96%-5.30%(n=5) and 4.68%-6.40%(n=5) respectively, the mean method recoveries and extraction recoveries were 97.178%-105.072%(n=5) and 73.333%-76.010%(n=5) respectively. The mean extraction recoveries of IS were more than 87.00%. CONCLUSION The method is sensitive, simple and accuracy, and it can be used for clinical study, espicially used in the patient with drug combination.
关键词
利奈唑胺 /
血清药物浓度 /
脑脊液药物浓度 /
胰液药物浓度 /
高相液相色谱法
{{custom_keyword}} /
Key words
linezolid /
serum concentration /
cerebrospinal fluid concentration /
pancreatic juice concentration /
HPLC
{{custom_keyword}} /
李春杏,付强,朱珠*.
高效液相色谱法测定人血清、脑脊液和胰液中利奈唑胺浓度[J]. 中国药学杂志, 2015, 50(4): 357-361 https://doi.org/10.11669/cpj.2015.04.020
LI Chun-xing,FU Qiang,ZHU Zhu*.
Determination of Linezolid in Human Serum, Cerebrospinal Fluid and Pancreatic Juice by HPLC[J]. Chinese Pharmaceutical Journal, 2015, 50(4): 357-361 https://doi.org/10.11669/cpj.2015.04.020
中图分类号:
R969
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] PALADINO J A. Linezolid: An oxazolidinone antimicrobial agent. Am J Health Syst Pharm, 2002,59(24):2413-2425.
[2] BOAK L M, LI J, NATION R L, et al. High-performance liquid chromatographic method for simple and rapid determination of linezolid in human plasma. Biomed Chrom, 2006,20(8):782-786.
[3] TOBIN C M, SUNDERLAND J, WHITE L O, et al. A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum.J Anti Chem, 2001,48(5):605-608.
[4] ClOS A, KUS K, OLEKSIAK J S. Determination of linezolid in human serum by reversed-phase high-performance liquid chromatography with ultraviolet and diode array detection. Acta Poloniae Pharm Drug Res, 2013,70(4):631-641.
[5] LI J S, WU H W. HPLC Determination of linezolid plasma concentration. Chin Chin J Mod Appl Pharm(中国现代应用药学), 2010,27(4):353-355.
[6] HUANG C K, ZhOU L L, WANG Z S. Determination of linezolid in human plasma by HPLC. Chin J Clin Pharm(中国临床药学杂志), 2011,20(2):105-108.
[7] MEI H K, BAI N, LIANG B B, et al. Determination concentration of linezolid in human plasma by HPLC. Chin J Clin Pharmacol(中国临床药理学杂志), 2012,28(4):295-297.
[8] PENG G W, STRYD R P, MURATA S, et al. Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography. J Pharm Biomed Anal, 1999,20(12):65-73.
[9] LI S J, MA Y, ZHANG Y, et al. Determination of linezolid concentration in human cerebrospinal fluid by high performance liquid chromatography. Chin J Hosp Pharm(中国医院药学杂志), 2012,32(10):785-788.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}